We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

62 hedge funds and large institutions have $338M invested in Akcea Therapeutics Inc in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 68 → 62 (-6)

25% less call options, than puts

Call options by funds: $4.38M | Put options by funds: $5.84M

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

39% less capital invested

Capital invested by funds: $554M → $338M (-$216M)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
24
Closed
14
Calls
$4.38M
Puts
$5.84M
Net Calls
-$1.46M
Net Calls Change
+$44K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.13M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.31M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.21M
4
ARTA
A.R.T. Advisors
New York
+$616K
5
UBS Group
UBS Group
Switzerland
+$576K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$19.2M
2
Citadel Advisors
Citadel Advisors
Florida
-$12.8M
3
State Street
State Street
Massachusetts
-$2.32M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.88M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$1M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$40.1K +$13.1K +616 +31%
Legal & General Group
52
Legal & General Group
United Kingdom
$37K – – –
Zurich Cantonal Bank
53
Zurich Cantonal Bank
Switzerland
$22K – – –
AIP
54
Ameritas Investment Partners
Nebraska
$20K – – –
KFS
55
Kelly Financial Services
Massachusetts
$10K – – –
Victory Capital Management
56
Victory Capital Management
Texas
$10K +$14.2K +668 New
Daiwa Securities Group
57
Daiwa Securities Group
Japan
$9K +$533 +25 +4%
Simplex Trading
58
Simplex Trading
Illinois
$1K -$21.7K -1,017 -91%
SIM
59
Sonora Investment Management
Arizona
$1K – – –
CFA
60
Carroll Financial Associates
North Carolina
$1K +$2.13K +100 New
Hudson Bay Capital Management
61
Hudson Bay Capital Management
Connecticut
– -$1.88M -80,000 Closed
American Century Companies
62
American Century Companies
Missouri
– -$748K -31,910 Closed
AQR Capital Management
63
AQR Capital Management
Connecticut
– -$517K -22,034 Closed
Renaissance Technologies
64
Renaissance Technologies
New York
– -$450K -19,200 Closed
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
– -$371K -17,421 Closed
Millennium Management
66
Millennium Management
New York
– -$332K -14,142 Closed
PPA
67
Parametric Portfolio Associates
Washington
– -$280K -11,955 Closed
GCP
68
GSA Capital Partners
United Kingdom
– -$280K -11,925 Closed
JG
69
Jefferies Group
New York
– -$254K -10,840 Closed
GAM
70
Gotham Asset Management
New York
– -$254K -10,829 Closed
Canada Life
71
Canada Life
Manitoba, Canada
– -$48K -2,062 Closed
AG
72
Aperio Group
California
– -$1K -37 Closed
GAM
73
Gemmer Asset Management
California
– +$21 +1 New
1 2
3

AKCA Hedge Fund Activity: Q3 2019 in Review

62 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2019, worth a combined $338M — down 39% from $554M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AKCA and 8 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 16 added.

The largest buyer was Vanguard Group, adding an estimated $2.13M. The largest seller was Fidelity Investments, cutting an estimated $19.2M.

  • 62 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2019, down from 68 in Q2 2019.
  • Funds reported $338M of Akcea Therapeutics Inc stock for Q3 2019, down 39% quarter-over-quarter.
  • 8 funds opened new Akcea Therapeutics Inc positions in Q3 2019 and 14 closed out, a net change of -6 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2019 was Vanguard Group, an estimated $2.13M added.
  • The largest Akcea Therapeutics Inc seller in Q3 2019 was Fidelity Investments, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2019.